These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32330592)

  • 1. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
    Çakici N; Sutterland AL; Penninx BWJH; Dalm VA; de Haan L; van Beveren NJM
    Brain Behav Immun; 2020 Aug; 88():547-558. PubMed ID: 32330592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
    Çakici N; Sutterland AL; Penninx BWJH; de Haan L; van Beveren NJM
    Psychol Med; 2021 Mar; 51(4):538-549. PubMed ID: 33653423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis.
    Pillinger T; Beck K; Gobjila C; Donocik JG; Jauhar S; Howes OD
    JAMA Psychiatry; 2017 Mar; 74(3):261-269. PubMed ID: 28097367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
    Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
    Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis.
    Wang L; Wang R; Liu L; Qiao D; Baldwin DS; Hou R
    Brain Behav Immun; 2019 Jul; 79():24-38. PubMed ID: 30797959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis.
    Islam MR; Sohan M; Daria S; Masud AA; Ahmed MU; Roy A; Shahriar M
    Int J Immunopathol Pharmacol; 2023; 37():3946320231198828. PubMed ID: 37625799
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
    Lee H; Song M; Lee J; Kim JB; Lee MS
    J Affect Disord; 2020 Apr; 266():57-62. PubMed ID: 32056928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
    Köhler CA; Freitas TH; Maes M; de Andrade NQ; Liu CS; Fernandes BS; Stubbs B; Solmi M; Veronese N; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
    Acta Psychiatr Scand; 2017 May; 135(5):373-387. PubMed ID: 28122130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.
    Shi Y; Luan D; Song R; Zhang Z
    Eur Neuropsychopharmacol; 2020 Dec; 41():40-51. PubMed ID: 32980240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.
    Qin XY; Zhang SP; Cao C; Loh YP; Cheng Y
    JAMA Neurol; 2016 Nov; 73(11):1316-1324. PubMed ID: 27668667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
    Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
    Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study.
    Yang KC; Liu MN; Liou YJ; Hu LY; Yang BH; Chou YH
    J Psychiatr Res; 2021 Mar; 135():174-180. PubMed ID: 33493946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
    Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between interleukin (IL)-6 and brain morphology in drug-naïve, first-episode major depressive disorder using surface-based morphometry.
    Kakeda S; Watanabe K; Katsuki A; Sugimoto K; Igata N; Ueda I; Igata R; Abe O; Yoshimura R; Korogi Y
    Sci Rep; 2018 Jul; 8(1):10054. PubMed ID: 29968776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis.
    Pillinger T; Osimo EF; Brugger S; Mondelli V; McCutcheon RA; Howes OD
    Schizophr Bull; 2019 Sep; 45(5):1120-1133. PubMed ID: 30407606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faster speed of onset of the depressive episode is associated with lower cytokine serum levels (IL-2, -4, -6, -10, TNF-α and IFN-γ) in patients with major depression.
    Buspavanich P; Adli M; Himmerich H; Berger M; Busche M; Schlattmann P; Bopp S; Bschor T; Richter C; Steinacher B; Stoppel C; Hindinger C; Meyer S; Hoffmann K; Stamm T; Gabriel A; Merkl A; Goerke-Arndt F; Köhler S; Sterzer P; Heinz A; Behr J; Fakhri H; Lang F; Lang UE; Ricken R
    J Psychiatr Res; 2021 Sep; 141():287-292. PubMed ID: 34271459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates and metabolic indicators of elevated fasting glucose in overweight/obese Chinese Han patients with first-episode and drug-naive major depressive disorder.
    Gao W; Deng Z; Cai X; Zhang D; Xiao H; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1102670. PubMed ID: 37008928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():534-7. PubMed ID: 24161452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.